-
Decoy Therapeutics expands patent portfolio to 7 families, 19 apps
-
Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire
-
Decoy Therapeutics (DCOY) files for 3.77M share offering by selling stockholders
-
Decoy Therapeutics (DCOY) files for 808K share offering by selling stockholders
-
Decoy Therapeutics advances antiviral pipeline toward clinical trials
-
Decoy Therapeutics joins Webull corporate communication platform
-
Ladenburg Thalmann Starts Decoy Therapeutics Inc. (DCOY) at Buy
-
Decoy Therapeutics partners with Gates Foundation on manufacturing platform


